MedTrace Logo

Clinical Trial for Idiopathic Hip Pain Using Peripheral Nerve Stimulation

NCT05074329 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2021-10-12

No results posted yet for this study

Summary

This is a prospective, randomized, multi-center study in which 300 evaluable subjects will be randomized 1:1 to receive Active or Delayed therapy with Moventis PNS. Subjects in the Delayed group will start with therapy at 3-month visit follow up.

Conditions

  • Idiopathic Hip Pain
  • Chronic Hip Pain

Interventions

DEVICE

Moventis PNS

Moventis PNS is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin.

Sponsors & Collaborators

  • Uro Medical Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2023-06-30
Completion
2024-06-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05074329 on ClinicalTrials.gov